Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry

References

• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2019 [cited 2020 Mar 15]. Available from: http://www.ginasthma.org
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373.
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology. 2017;22(4):651–661.
   PubMed Web of Science ®Google Scholar
• Polverino E, Goeminne PC, McDonnell MJ, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629.
   PubMed Web of Science ®Google Scholar
• Seitz AE, Olivier KN, Adjemian J, et al. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142(2):432–439.
   PubMed Web of Science ®Google Scholar
• Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis. 2017;14(4):377–384.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Polverino E, Aksamit T. Bronchiectasis and chronic airway disease: it is not just about asthma and COPD. Chest. 2018;154(4):737–739.
   PubMed Web of Science ®Google Scholar
• Aliberti S, Sotgiu G, Lapi F, et al. Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med. 2020;20(1):15.
   PubMed Web of Science ®Google Scholar
• Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018;52(3):1800328.
   PubMed Web of Science ®Google Scholar
• Paganin F, Trussard V, Seneterre E, et al. Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis. 1992;146(4):1084–1087.
   PubMed Web of Science ®Google Scholar
• Oguzulgen IK, Kervan F, Ozis T, et al. The impact of bronchiectasis in clinical presentation of asthma. South Med J. 2007;100(5):468–471.
   PubMed Web of Science ®Google Scholar
• Bisaccioni C, Aun MV, Cajuela E, et al. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. Clinics (Sao Paulo). 2009;64(8):769–773.
   PubMed Web of Science ®Google Scholar
• Luján M, Gallardo X, Amengual MJ, et al. Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels. Biomed Res Int. 2013;2013:109219.
   PubMed Web of Science ®Google Scholar
• Kang HR, Choi GS, Park SJ, et al. The effects of bronchiectasis on asthma exacerbation. Tuberc Respir Dis (Seoul). 2014;77(5):209–214.
   PubMedGoogle Scholar
• Weatherburn CJ, Guthrie B, Mercer SW, et al. Comorbidities in adults with asthma: population-based cross-sectional analysis of 1.4 million adults in Scotland. Clin Exp Allergy. 2017;47(10):1246–1252.
   PubMed Web of Science ®Google Scholar
• Henkle E, Aksamit TR, Barker AF, et al. Pharmacotherapy for non-cystic fibrosis bronchiectasis: results from an NTM info & research patient survey and the bronchiectasis and NTM research registry. Chest. 2017;152(6):1120–1127.
   PubMed Web of Science ®Google Scholar
• Perez-Miranda J, Traversi L, Polverino E. Bronchiectasis in severe asthma: a distinct phenotype? Curr Opin Pulm Med. 2019;25(1):71–78.
   PubMed Web of Science ®Google Scholar
• Gupta S, Siddiqui S, Haldar P, et al. Qualitative analysis of high-resolution CT scans in severe asthma. Chest. 2009;136(6):1521–1528.
   PubMed Web of Science ®Google Scholar
• Menzies D, Holmes L, McCumesky G, et al. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66(5):679–685.
   PubMed Web of Science ®Google Scholar
• Dimakou K, Gousiou A, Toumbis M, et al. Investigation of bronchiectasis in severe uncontrolled asthma. Clin Respir J. 2018;12(3):1212–1218.
   PubMed Web of Science ®Google Scholar
• Coman I, Pola-Bibián B, Barranco P, et al. Bronchiectasis in severe asthma: clinical features and outcomes. Ann Allergy Asthma Immunol. 2018;120(4):409–413.
   PubMed Web of Science ®Google Scholar
• Padilla-Galo A, Olveira C, Fernández de Rota-garcia L, et al. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients. Respir Res. 2018;19(1):43.
   PubMedGoogle Scholar
• Kim S, Lee CH, Jin KN, et al. Severe Asthma phenotypes classified by site of airway involvement and remodeling via chest CT scan. J Investig Allergol Clin Immunol. 2018;28(5):312–320.
   PubMed Web of Science ®Google Scholar
• Heffler E, Blasi F, Latorre M, et al. SANI network. The Severe Asthma Network in Italy: findings and perspectives. J Allergy Clin Immunol Pract. 2019;7(5):1462–1468.
   PubMed Web of Science ®Google Scholar
• Polverino EPP, Aliberti S, Blasi F, et al. Self-reported asthma as a co-morbidity of bronchiectasis in the EMBARC registry. Second World Bronchiectasis congress; 2017 Jul 6–8; Milan.
   Google Scholar
• Dupin C, Marchand-Adam S, Favelle O, et al. Asthma and hypogammaglobulinemia: an asthma phenotype with low type 2 inflammation. J Clin Immunol. 2016;36(8):810–817.
   PubMed Web of Science ®Google Scholar
• Crimi C, Ferri S, Crimi N. Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol. 2019;19(1):46–52.
   PubMed Web of Science ®Google Scholar
• Senna G, Guerriero M, Paggiaro PL, et al. SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma. Clin Mol Allergy. 2017;15:9.
   PubMedGoogle Scholar
• Paganin F, Séneterre E, Chanez P, et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med. 1996;153(1):110–114.
   PubMed Web of Science ®Google Scholar
• Grenier P, Mourey-Gerosa I, Benali K, et al. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability. Eur Radiol. 1996;6(2):199–206.
   PubMed Web of Science ®Google Scholar
• Takemura M, Niimi A, Minakuchi M, et al. Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest. 2004;125(4):1352–1358.
   PubMed Web of Science ®Google Scholar
• Backman H, Jansson SA, Stridsman C, et al. Severe asthma-A population study perspective. Clin Exp Allergy. 2019;49(6):819–828.
   PubMed Web of Science ®Google Scholar
• Wong-You-Cheong JJ, Leahy BC, Taylor PM, et al. Airways obstruction and bronchiectasis: correlation with duration of symptoms and extent of bronchiectasis on computed tomography. Clin Radiol. 1992;45(4):256–259.
   PubMed Web of Science ®Google Scholar
• Park CS, Müller NL, Worthy SA, et al. Airway obstruction in asthmatic and healthy individuals: inspiratory and expiratory thin-section CT findings. Radiology. 1997;203(2):361–367.
   PubMed Web of Science ®Google Scholar
• Lynch DA, Newell J, Hale V, et al. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. AJR Am J Roentgenol. 1999;173(1):53–58.
   PubMed Web of Science ®Google Scholar
• Goeminne PC, Scheers H, Decraene A, et al. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir Res. 2012;13(1):21.
   PubMedGoogle Scholar
• Lonni S, Chalmers JD, Goeminne PC, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764–1770.
   PubMed Web of Science ®Google Scholar
• Amorim A, Bento J, Vaz AP, et al. Bronchiectasis: a retrospective study of clinical and aetiological investigation in a general respiratory department. Rev Port Pneumol. 2006;21(1):5–10.
   Google Scholar
• Buscot M, Pottier H, Marquette CH, et al. phenotyping adults with non-cystic fibrosis bronchiectasis: a 10-year cohort study in a French Regional University Hospital Center. Respiration. 2016;92(1):1–8.
   PubMed Web of Science ®Google Scholar
• Dimakou K, Triantafillidou C, Toumbis M, et al. Non CF-bronchiectasis: aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir Med. 2016;116:1–7.
   PubMed Web of Science ®Google Scholar
• Olveira C, Padilla A, Martínez-García MÁ, et al. Etiology of bronchiectasis in a cohort of 2047 patients. An analysis of the Spanish historical bronchiectasis registry. Arch Bronconeumol. 2017;53(7):366–374.
   PubMed Web of Science ®Google Scholar
• Mäntylä J, Mazur W, Törölä T, et al. Asthma as aetiology of bronchiectasis in Finland. Respir Med. 2019;152:105–111.
   PubMed Web of Science ®Google Scholar
• Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007;101(6):1163–1170.
   PubMed Web of Science ®Google Scholar
• Laurent F, Latrabe V, Raherison C, et al. Functional significance of air trapping detected in moderate asthma. Eur Radiol. 2000;10(9):1404–1410.
   PubMed Web of Science ®Google Scholar
• Tsikrika S, Dimakou K, Papaioannou AI, et al. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis. Cytokine. 2017;99:281–286.
   PubMed Web of Science ®Google Scholar
• Shoemark A, Devaraj A, Meister M, et al. Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity. Respir Med. 2011;105(6):885–891.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Lim HJ, Park JS, et al. Measurement of fractional exhaled nitric oxide in stable bronchiectasis. Tuberc Respir Dis (Seoul). 2013;74(1):7–14.
   PubMedGoogle Scholar
• Chen FJ, Liao H, Huang XY, et al. Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma. J Thorac Dis. 2016;8(5):992–999.
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Scioscia G, Lacedonia D, et al. Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab. J Asthma Allergy. 2019;12:83–90.
   PubMed Web of Science ®Google Scholar
• Rademacher J, Konwert S, Fuge J, et al. Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series. Eur Respir J. 2020;55(1):1901333.
   PubMed Web of Science ®Google Scholar
• Radovanovic D, Santus P, Blasi F, et al. A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018;145:120–129.
   PubMed Web of Science ®Google Scholar